Drug Shortage Report for FOQUEST
Report ID | 179942 |
Drug Identification Number | 02470322 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 55MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-01-05 |
Actual start date | 2023-01-05 |
Estimated end date | 2023-02-17 |
Actual end date | 2023-02-16 |
Shortage status | Resolved |
Updated date | 2023-02-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2023-02-17 | English | Compare |
v17 | 2023-02-16 | French | Compare |
v16 | 2023-02-16 | English | Compare |
v15 | 2023-02-09 | French | Compare |
v14 | 2023-02-09 | English | Compare |
v13 | 2023-02-02 | French | Compare |
v12 | 2023-02-02 | English | Compare |
v11 | 2023-01-26 | French | Compare |
v10 | 2023-01-26 | English | Compare |
v9 | 2023-01-20 | French | Compare |
v8 | 2023-01-20 | English | Compare |
v7 | 2023-01-13 | French | Compare |
v6 | 2023-01-13 | English | Compare |
v5 | 2023-01-09 | French | Compare |
v4 | 2023-01-09 | English | Compare |
v3 | 2023-01-06 | English | Compare |
v2 | 2023-01-05 | French | Compare |
v1 | 2023-01-05 | English | Compare |
Showing 1 to 18 of 18